GREENLIGHT CLINICAL
LIVE

Serial Number

79239928

Owner

GREENLIGHT CLINICAL PTY LTD

Attorney

Christie Baty Hudgins

Filing Date

May 2, 2018

Add to watchlist:

No watchlists yet
View on USPTO

GREENLIGHT CLINICAL Trademark

Serial Number: 79239928 • Registration: 5887531

GREENLIGHT CLINICAL is a trademark filed by GREENLIGHT CLINICAL PTY LTD on May 2, 2018. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

GREENLIGHT CLINICAL PTY LTD

L2,

Entity Type: 81

Trademark Details

Filing Date

May 2, 2018

Registration Date

October 22, 2019

Published for Opposition

August 6, 2019

Cancellation Date

May 8, 2026

Goods & Services

Pharmaceutical advisory services; Advisory services relating to medical services; Advisory services relating to pharmaceutical products; Advisory services relating to pharmacology; Advisory services relating to medical problems; Advisory services relating to diseases; Compilation of medical reports; Consultancy and advisory services in relation to medical services; Health care consultancy services; Medical advisory services; Medical clinic services; Medical consulting services relating to offshore medical services; Medical equipment rental; Medical services in the form of Oncology, Ophthalmology, Cardiovascular, CNS, and Dermatology; Ophthalmological services; Medical services in the form of Ophthalmology; Pharmacy advisory services in the form of providing information about the dispensing of pharmaceuticals; Provision of information relating to medicine; Rental of equipment for medical purposes; Rental of medical apparatus; Rental of medical equipment and instruments

Conducting clinical trials for others; Advisory services relating to scientific research; Analytical laboratory services in the field of pharmacodynamics and pharmacokinetics; Conducting of scientific feasibility studies; Conducting surveys; Evaluation of performance against bench-mark references, namely, quality control for others; Medical laboratory services; Management of scientific research projects, namely, conducting scientific research; Medical research; Pharmaceutical research services; Preparation of reports relating to scientific research; Preparation of scientific reports; Preparation of technical manuals in the form of providing information on the chemical properties of pharmaceuticals; Product testing; Advisory services relating to product testing; Quality control; Quality control testing; Scientific research into the development of new products; Research relating to medicine; Research relating to pharmaceuticals; Safety testing of products; Scientific laboratory services; Scientific research; Scientific research in the field of pharmacy; Services for assessing the efficiency of pharmaceuticals; Services for assessing the safety of pharmaceuticals

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jun 25, 2026 NREP
CANCELLED SECTION 71
May 8, 2026 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Jul 25, 2025 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 22, 2024 REM3
NEW REPRESENTATIVE AT IB RECEIVED
May 20, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 6, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 13, 2020 FICS
FINAL DISPOSITION PROCESSED
Feb 13, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 22, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 22, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 6, 2019 NPUB
PUBLISHED FOR OPPOSITION
Aug 6, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Aug 2, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 17, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 17, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 17, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 18, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 18, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 18, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 18, 2019 CNEA
ASSIGNED TO LIE
Jun 14, 2019 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 30, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 30, 2018 GNSL
SUSPENSION LETTER WRITTEN
Nov 30, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 29, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 28, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 28, 2018 TROA
REFUSAL PROCESSED BY IB
Oct 13, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 22, 2018 RFCS
REFUSAL PROCESSED BY MPU
Sep 22, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 19, 2018 RFCR
NON-FINAL ACTION WRITTEN
Sep 18, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 18, 2018 MAFR
ASSIGNED TO EXAMINER
Sep 12, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 12, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 6, 2018 REPR